PTPRC and acute myeloid leukemia: Overall, AML hCD45+ cell engraftment in NSGS mice was higher compared to the NSG and NBSGW mouse models (NSG, median CD45+ = 12.65%; NSGS, median hCD45+ = 50.80%; NBSGW, median hCD45+ = 20.45) (Figure 1B).